Family resemblance: How T cells could fight many coronaviruses at once
LA JOLLA, CA—Scientists at La Jolla Institute for Immunology (LJI) are investigating how the immune system’s T cells react to
Even as SARS-CoV-2 mutates, some human antibodies fight back
LA JOLLA, CA—An anonymous San Diego resident has become a fascinating example of how the human immune system fights SARS-CoV-2.
Shane Crotty receives AAI-BioLegend Herzenberg Award for B cell research
LA JOLLA, CA—La Jolla Institute for Immunology (LJI) Professor Shane Crotty, Ph.D., has been awarded the 2023 AAI-BioLegend Herzenberg Award
Durable SARS-CoV-2 antibodies bind to two viral targets at once
A new study led by scientists at La Jolla Institute for Immunology (LJI) shows how ideal antibodies against SARS-CoV-2 hit their marks.
LJI scientists reflect on what it means to make the “Highly Cited” list
A record number of LJI researchers have been named to the 2022 list, including two early career scientists
Get to know Ferhat Ay, Ph.D., the chromosome cartographer
How computational biology is propelling the field of immunology
The longer the bootcamp, the better the antibodies
LA JOLLA, CA—Researchers at La Jolla Institute for Immunology (LJI) have discovered how the immune system can transform into an
Your body remembers common cold coronaviruses from childhood. How can you get the same immunity to COVID-19?
LA JOLLA, CA—For a glimpse into the future of SARS-CoV-2 immunity, scientists at La Jolla Institute for Immunology (LJI) are
LJI scientists publish first head-to-head comparison of four COVID-19 vaccines
Correction: A previous version of this article incorrectly stated that “Participants given the Janssen/J&J vaccine had the highest percentage of
Op-Ed: What will it take to make a universal COVID vaccine?
As California emerges from Omicron, other places are again in lockdown or facing record caseloads after trying and failing to
Current vaccines teach T cells to fight Omicron
Four COVID-19 vaccines prompt the body to make effective, long-lasting T cells against SARS-CoV-2.
LJI and Charles River Laboratories to collaborate on COVID-19 research
New agreement paves the way for better mouse models to study how the human immune system fights SARS-CoV-2